Form 4: Vericel Corp Executive Jonathan Hopper Executes Stock Option and Sells Shares

Chief Medical Officer Jonathan Hopper exercised stock options and sold 10,000 shares of Vericel Corp stock at $49.83 per share on September 3, 2024.

Summary

• On September 3, 2024, Jonathan Hopper, Chief Medical Officer of Vericel Corp, exercised stock options to acquire 10,000 shares at an exercise price of $10.95.
• Simultaneously, Hopper sold 10,000 shares of Vericel Corp stock at a price of $49.83 per share.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 28, 2024.
• Following these transactions, Hopper directly owns 58,229 shares of Vericel Corp common stock.
• Hopper also holds options to purchase 12,604 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions appear to be part of a pre-planned trading strategy. There is no indication of positive or negative sentiment towards the company's future prospects.

Industry Context

Executive stock transactions are common and provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans allow insiders to sell shares over a predetermined period, mitigating concerns about insider trading.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market.
• The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates